temozolomide has been researched along with Pneumonia in 2 studies
Pneumonia: Infection of the lung often accompanied by inflammation.
| Excerpt | Relevance | Reference |
|---|---|---|
| " All three were found to have been treated with temozolomide after surgery for malignant glioma." | 7.78 | Fatal pneumonia associated with temozolomide therapy in patients with malignant glioma. ( Abe, S; Azuma, A; Fujita, K; Gemma, A; Hayashi, H; Kobayashi, K; Kokuho, N; Morimoto, T; Saito, Y; Tanaka, T, 2012) |
| "The prognosis for recurrent/progressive Ewing sarcoma (ES) remains poor." | 6.74 | Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience. ( Casey, DA; Chou, AJ; Merchant, MS; Merola, PR; Meyers, PA; Price, AP; Wexler, LH, 2009) |
| " All three were found to have been treated with temozolomide after surgery for malignant glioma." | 3.78 | Fatal pneumonia associated with temozolomide therapy in patients with malignant glioma. ( Abe, S; Azuma, A; Fujita, K; Gemma, A; Hayashi, H; Kobayashi, K; Kokuho, N; Morimoto, T; Saito, Y; Tanaka, T, 2012) |
| "The prognosis for recurrent/progressive Ewing sarcoma (ES) remains poor." | 2.74 | Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience. ( Casey, DA; Chou, AJ; Merchant, MS; Merola, PR; Meyers, PA; Price, AP; Wexler, LH, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casey, DA | 1 |
| Wexler, LH | 1 |
| Merchant, MS | 1 |
| Chou, AJ | 1 |
| Merola, PR | 1 |
| Price, AP | 1 |
| Meyers, PA | 1 |
| Hayashi, H | 1 |
| Saito, Y | 1 |
| Kokuho, N | 1 |
| Morimoto, T | 1 |
| Kobayashi, K | 1 |
| Tanaka, T | 1 |
| Abe, S | 1 |
| Fujita, K | 1 |
| Azuma, A | 1 |
| Gemma, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessment of MGMT Promoter Methylation and Clinical Benefit From Temozolomide-based Therapy in Ewing Sarcoma Patients[NCT03542097] | 82 participants (Actual) | Observational | 2014-04-15 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for temozolomide and Pneumonia
| Article | Year |
|---|---|
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Camptotheci | 2009 |
1 other study available for temozolomide and Pneumonia
| Article | Year |
|---|---|
Fatal pneumonia associated with temozolomide therapy in patients with malignant glioma.
Topics: Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Drug Labeling; Fatal Outcome; Female; Glioma; | 2012 |